Clinical trial
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI…
NCT00480454 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00480454 |
|---|---|
| Title | Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines |
| Official title | An Open Randomized Dose Selection Study Evaluating the Safety, Immunogenicity, and Impact of a TB Vaccine, MVA85A, on the Immunogenicity of EPI Vaccines Administered Simultaneously to Healthy Infants Previously Vaccinated With BCG. |
| Lead sponsor | University of Oxford, Other |
| Collaborators | Medical Research Council |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | TB |
| Intervention type | Biological |
| Interventions | MVA 85A |
| Enrollment | 214 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | May 31, 2007 |
| Last update posted | Feb 9, 2010 |
| Countries | The Gambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: